CIK: 0001019231 · Show all filings
Period: Q1 2018 (← Previous) (Next →)
Filing Date: May 11, 2018
Total Value ($000): $253,697 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TRUST | 872,645 | $229,637 | 90.5% | $263.15 | — | ETFS | 78462F103 |
| — | AEGLEA BIOTHERAPEUTICS INC | 524,929 | $5,207 | 2.1% | $6.41 | — | COM | 00773J103 |
| TXN | TEXAS INSTRUMENTS INC | 32,000 | $3,324 | 1.3% | $56.41 | +53.9% | COM | 882508104 |
| VEA | VANGUARD FTSE DEV MKTS | 73,284 | $3,243 | 1.3% | $38.68 | — | ETFS | 921943858 |
| VOO | VANGUARD 500 INDEX FUND | 12,076 | $2,923 | 1.2% | $182.90 | — | ETFS | 922908363 |
| VOE | VANGUARD MID-CAP VALUE ETF | 26,356 | $2,883 | 1.1% | $85.98 | — | ETFS | 922908512 |
| VWO | VANGUARD MSCI EMERGING MKTS | 56,389 | $2,649 | 1.0% | $38.55 | — | ETFS | 922042858 |
| VDE | VANGUARD ENERGY ETF | 11,445 | $1,057 | 0.4% | $111.17 | — | ETFS | 92204A306 |
| — | BIO-PATH HOLDINGS INC | 383,088 | $766 | 0.3% | $2.00 | — | COM | 09057N201 |
| — | APOLLO ENDOSURGERY INC | 119,200 | $747 | 0.3% | $12.52 | — | COM | 03767D108 |
| VNQ | VANGUARD REIT ETF | 9,784 | $738 | 0.3% | $73.04 | — | ETFS | 922908553 |
| LXRX | LEXICON PHARMACEUTICALS INC | 35,714 | $306 | 0.1% | $7.34 | +25.9% | COM | 528872302 |
| — | PLX PHARMA INC | 62,673 | $210 | 0.1% | $6.14 | — | COM | 72942A107 |
| POR | PORTLAND GENERAL ELECTRIC CO | 118 | $5 | 0.0% | $20.00 | +51.1% | COM | 736508847 |
| AAPL | APPLE INC | 14 | $2 | 0.0% | $39.08 | +3.4% | COM | 037833100 |